Medical professionals at healthcare conference

Scientific Congresses in Gastroenterology

Scientific Congresses and Resources

This is not intended to be a comprehensive resource of all congresses and congress materials across therapeutic and disease areas. Congress materials may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Takeda does not recommend the use of any Takeda product beyond the approved labeling. Any decisions regarding the usage of a Takeda product beyond the approved labeling are left to the discretion of the healthcare professional. Takeda makes no representations about whether investigational compounds or unapproved uses will be approved by the FDA.

North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), 2025

November 5 - 8, 2025 | Link to Event

Annual forum for participants to learn about the latest advances in pediatric gastroenterology, hepatology, and nutrition, and to discuss current topics in clinical applications.

American College of Allergy, Asthma & Immunology (ACAAI), 2025

November 6 - 10, 2025 | Link to Event

Global meeting featuring thought leaders from around the world focused on advancing patient care in allergy and immunology.

Advances in Inflammatory Bowel Diseases (AIBD), 2025

December 8 - 10, 2025 | Link to Event

An all-encompassing event providing real-world clinical education, case studies and new evidence-based approaches in IBD management.

Crohn's & Colitis Congress (CCC), 2026

January 22 - 24, 2026 | Link to Event

Annual conference for a multidisciplinary community of practitioners and researchers focusing on inflammatory bowel disease (IBD) by pairing best practices in clinical care with innovative research.

Digestive Disease Week (DDW), 2026

May 2 - 5, 2026 | Link to Event

Global meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.

Academy of Managed Care Pharmacy Nexus (AMCP Nexus), 2025

October 27 - 30, 2025

Annual event with more than 2,500 members and non-members of the AMCP to engage on the latest innovations and most intentional networking in managed care pharmacy.

Eohilia™ (budesonide oral suspension)

  • Healthcare burden of eosinophilic esophagitis by disease severity: a retrospective cohort study of US health insurance claims data

American College of Gastroenterology (ACG), 2025

October 24 - 29, 2025

Premier event for clinicians and the general public about digestive disorders and the latest trends in GI technology and therapeutics.

Entyvio® (vedolizumab)

  • Demographics and Clinical Characteristics of Patients With Ulcerative Colitis Receiving First-line Advanced Therapies Categorized in AGA Guidelines as Lower, Intermediate, and Higher Efficacy
  • Evaluation of the Relationship Between Endoscopic Disease Severity and Treatment Choice for Patients with Ulcerative Colitis Using a Real-World Data Set Linked to Endoscopic Videos Evaluated with Computer Vision

Eohilia™ (budesonide oral suspension)

  • Effect of social determinants of health on healthcare costs and access to care in patients with eosinophilic esophagitis: a retrospective cohort study of US health insurance claims data
  • Using health insurance claims data to determine the severity of eosinophilic esophagitis in patients in the USA: a retrospective cohort study

Congress of the International Intestinal Rehabilitation and Transplantation Association (CIIRTA), 2025

September 10 - 13, 2025

The International Intestinal Rehabilitation and Transplantation Association (IIRTA) aims to serve its scientific community in providing a forum for open exchange of knowledge and expertise to promote intestinal rehabilitation and transplantation as a safe, innovative science involving nutritional, medical, surgical and transplant therapies through education, policy development and research. Every two years, the IIRTA brings together clinicians and scientists from all over the world in the fields of intestinal rehabilitation and transplantation.

Gattex® (teduglutide)

  • Effect of Teduglutide Treatment on Stool Characteristics in Children with Short Bowel Syndrome-Associated Intestinal Failure and Colon-in-Continuity

Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), 2025

September 4 - 6, 2025

Conference specifically designed by advanced practice providers (APPs) for the purpose of meeting the educational needs of APPs who specialize in the management of patients with GI disorders and chronic liver disease.

Entyvio® (vedolizumab)

  • First-line Advanced Therapy Treatment Patterns for Ulcerative Colitis and Concordance With 2024 American Gastroenterological Association Clinical Guidelines Among Advanced Practice Providers
  • Impact of Vedolizumab on Bowel Urgency in Patients With Ulcerative Colitis, Measured Using Selected Items from the IBD Questionnaire as a Proxy Assessment Tool: a Post Hoc Analysis of the GEMINI 1, VISIBLE 1, and VARSITY Clinical Trials

Professional Society for Health Economics and Outcomes Research (ISPOR), 2025

May 13 - 16, 2025

Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

Eohilia™ (budesonide oral suspension)

  • Eosinophilic esophagitis-related healthcare resource utilization and associated costs for payers and patients: a retrospective cohort study of US health insurance claims data
  • Eosinophilic esophagitis-related healthcare resource utilization: a retrospective cohort study of US health insurance claims data

Digestive Disease Week (DDW), 2025

May 3 - 6, 2025

Global meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.

Eohilia™ (budesonide oral suspension)

  • Effect of disease severity on histologic, dysphagia symptom and endoscopic outcomes in patients with eosinophilic esophagitis: post hoc analysis from a phase 3 trial of budesonide oral suspension
  • Healthcare resource utilization and associated costs in patients with eosinophilic esophagitis: a retrospective cohort study of US health insurance claims data
  • Demographics and social determinants of health for patients with eosinophilic esophagitis: a retrospective cohort study of US health insurance claims data

Gattex® (teduglutide)

  • Long-term Effectiveness of Teduglutide in Adults With Short Bowel Syndrome-Associated Intestinal Failure: Interim Analysis From a Global Multicenter Registry Study
  • Long-term Effectiveness of Teduglutide in Adults With Short Bowel Syndrome-Associated Intestinal Failure: Interim Analysis of the US Subpopulation From a Global Multicenter Registry Study

Entyvio® (vedolizumab)

  • Mucosal Transcriptomic Analysis Confirms Subpopulations Identified by Symptom Response Trajectories for Response to Vedolizumab and Sharpens Molecular Analysis of Therapeutic Mechanisms by Better Population Definition
  • Patient Characteristics, Disease Symptoms, and Treatment Patterns of Patients With Ulcerative Colitis and Crohn's Disease from the United States: Results from a Retrospective, Longitudinal Cohort Study
  • A Matching-Adjusted Indirect Comparison (MAIC) of Vedolizumab Versus Risankizumab in Patients with Moderately to Severely Active Crohn's Disease
  • Improvement in Biomarkers in Patients With Ulcerative Colitis Treated With Vedolizumab: Results from the Continuing VERDICT Trial
  • Impact of Vedolizumab on Bowel Urgency in Patients With Ulcerative Colitis, Measured Using Selected Items from the IBD Questionnaire as a Proxy Assessment Tool: a Post Hoc Analysis of the GEMINI 1, VISIBLE 1, and VARSITY Clinical Trials

American Society for Parenteral and Enteral Nutrition (ASPEN), 2025

March 22 - 25, 2025

Annual global conference for interdisciplinary, clinical nutrition leaders, providing the latest in clinical nutrition research, education, and products.

Annual Meeting American Academy of Allergy Asthma and Immunology (AAAAI), 2025

February 28 - March 3, 2025

Premier global educational event for allergists and immunologists, with thousands of attendees each year, discussing allergies, asthma, and immune deficiency disorders.

Eohilia™ (budesonide oral suspension)

  • Effect of randomized treatment withdrawal of budesonide oral suspension on the durability of dysphagia symptom improvement in patients with eosinophilic esophagitis: a post hoc analysis of a phase 3, 36-week trial
  • High incidence and prevalence of eosinophilic esophagitis in the USA identified: an analysis of US health insurance claims data

European Crohn's and Colitis Organisation (ECCO), 2025

February 19 - 22, 2025

Annual global congress structured around basic science, traditional medicine and clinical sessions given by some of the world's top GI specialists.

Western Society of Allergy, Asthma and Immunology (WSAAI), 2025

February 9 - 13, 2025

Annual scientific session uniting allergists, immunologists, nurses, and physician assistants aimed at maintaining the highest standard of practice in allergy care.

Eohilia™ (budesonide oral suspension)

  • Safety of short-term therapy with budesonide oral suspension for eosinophilic esophagitis: an integrated safety analysis of phase 2 and 3 clinical studies

Crohn's & Colitis Congress (CCC), 2025

February 6 - 8, 2025

Annual conference for a multidisciplinary community of practitioners and researchers focusing on inflammatory bowel disease (IBD) by pairing best practices in clinical care with innovative research.

Advances in Inflammatory Bowel Diseases (AIBD), 2024

December 9 - 11, 2024

An all-encompassing event providing real-world clinical education, case studies and new evidence-based approaches in IBD management.

World Congress of Pediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN), 2024

December 4 - 7, 2024

Annual forum for participants to learn about the latest advances in pediatric gastroenterology, hepatology, and nutrition, and to discuss current topics in clinical applications.

Gattex® (teduglutide)

  • Long-Term Safety and Effectiveness of Teduglutide in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure: An Observational, Prospective, Multicenter Registry

Professional Society for Health Economics and Outcomes Research (ISPOR Europe), 2024

November 17 - 20, 2024

The conference program centers on the importance of scientific evidence in understanding and improving the health and well-being of people across the globe.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN), 2024

November 6 - 9, 2024

Annual forum for participants to learn about the latest advances in pediatric gastroenterology, hepatology, and nutrition, and to discuss current topics in clinical applications.

Eohilia™ (budesonide oral suspension)

  • Safety of short-term therapy with budesonide oral suspension for eosinophilic esophagitis: an integrated analysis of adolescent safety data